News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
300,012 Results
Type
Article (43242)
Company Profile (115)
Press Release (256655)
Section
Business (82407)
Career Advice (502)
Deals (9076)
Drug Delivery (33)
Drug Development (52228)
Employer Resources (47)
FDA (6899)
Job Trends (6291)
News (146855)
Policy (10244)
Tag
Academia (2543)
Alliances (21821)
Alzheimer's disease (754)
Antibody-drug conjugate (ADC) (63)
Approvals (6863)
Artificial intelligence (59)
Bankruptcy (51)
Best Places to Work (5496)
Biotechnology (100)
Breast cancer (97)
Cancer (980)
Career advice (445)
CAR-T (81)
Cell therapy (261)
Clinical research (39854)
Collaboration (232)
Compensation (45)
COVID-19 (1688)
C-suite (79)
Cystic fibrosis (59)
Data (799)
Diabetes (57)
Diagnostics (2672)
Earnings (19597)
Events (40077)
Executive appointments (239)
FDA (7170)
Funding (186)
Gene editing (54)
Gene therapy (159)
GLP-1 (229)
Government (1647)
Healthcare (8473)
Infectious disease (1734)
Inflammatory bowel disease (62)
Interviews (75)
IPO (4539)
Job creations (1020)
Job search strategy (403)
Layoffs (152)
Legal (1323)
Liver cancer (55)
Lung cancer (181)
Lymphoma (55)
Manufacturing (86)
Medical device (3743)
Medtech (3746)
Mergers & acquisitions (4621)
Metabolic disorders (143)
Neuroscience (899)
NextGen Class of 2024 (2656)
Non-profit (2136)
Northern California (799)
Obesity (64)
Opinion (70)
People (35697)
Phase I (14046)
Phase II (18019)
Phase III (12000)
Pipeline (281)
Postmarket research (1414)
Preclinical (6798)
Press Release (59)
Prostate cancer (44)
Radiopharmaceuticals (140)
Rare diseases (163)
Real estate (2141)
Regulatory (7966)
Research institute (1853)
Resumes & cover letters (49)
Southern California (683)
Startups (1775)
United States (6654)
Vaccines (313)
Date
Today (65)
Last 7 days (445)
Last 30 days (1962)
Last 365 days (18257)
2024 (16635)
2023 (20552)
2022 (25490)
2021 (27261)
2020 (24412)
2019 (20049)
2018 (14993)
2017 (15349)
2016 (14805)
2015 (17324)
2014 (12446)
2013 (11516)
2012 (11501)
2011 (11442)
2010 (10328)
Location
Africa (329)
Arizona (50)
Asia (19847)
Australia (4295)
California (1733)
Canada (503)
China (154)
Colorado (64)
Connecticut (68)
Europe (46443)
Florida (190)
Illinois (141)
Indiana (57)
Maryland (266)
Massachusetts (1357)
Minnesota (95)
New Jersey (489)
New York (531)
North Carolina (366)
Northern California (799)
Ohio (83)
Pennsylvania (402)
South America (406)
Southern California (683)
Texas (241)
Washington State (262)
300,012 Results for "universal cells".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Genetown
Cellular Origins and Cell and Gene Therapy Catapult Collaborate to Demonstrate Universal Automation of CGT Manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies, and the Cell and Gene Therapy Catapult, an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, announced a collaboration to demonstrate universal automation of CGT manufacturing.
May 29, 2024
·
4 min read
Pharm Country
Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024
Coeptis Therapeutics Holdings, Inc. announced today that the Company has been selected for an oral presentation of the abstract titled Developing A First-In-Class Universal Allogeneic Snap-Car NK Cell Therapy at the International Society for Cell & Gene Therapy 2024, being held May 28th to June 1st in Vancouver, Canada.
May 8, 2024
·
6 min read
Press Releases
Phio Announces Data Showcasing INTASYL’s Role in Helping Immune Cells Target and Kill Cancer Cells
INTASYL compounds also improve the functionality and outcomes of adoptive cell therapies such as NK, TIL and CAR-T
October 7, 2024
·
3 min read
Drug Delivery
The Next Frontier: Industrializing Cell Therapy Manufacturing
Q&A: Development Scientist at AGC Biologics Sara Morlacchi analyzes the growth of the cell therapy industry and barriers for cost and accessibility.
April 29, 2024
·
7 min read
·
Sara Morlacchi, Cell Process Development Manager, AGC Biologics
BioForest
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
BioLife Solutions, Inc., a leading supplier of bioproduction tools and services for the cell and gene therapy and broader biopharma markets, announced the introduction of the CryoCase, an addition to its CellSeal product line.
May 29, 2024
·
2 min read
Job trends
Cell Therapy Biotechs Hunt for Autoimmune Expertise in Pivot From Oncology
In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right expertise is in place to tackle the new disease area.
November 6, 2024
·
6 min read
·
Annalee Armstrong
Press Releases
Novellia and University of Alabama at Birmingham Study Examines Biomarker Testing Practices for Non-Small Cell Lung Cancer
October 1, 2024
·
3 min read
Business
Evergreen Theragnostics announces licensing of EVG321 from Medical University of Innsbruck and enters clinical development of Radioligand Therapies in small cell lung cancer
Evergreen Theragnostics, Inc. today announced that they have entered into a collaboration and licensing-agreement with the Medical University of Innsbruck (MUI), a leading European research institution to advance the development of novel radiopharmaceuticals.
May 21, 2024
·
3 min read
Press Releases
HELP Therapeutics announces FDA clearance of IND application for universal iPSC-derived HiCM-188 cell therapy for the treatment of end-stage heart failure
October 22, 2024
·
4 min read
1 of 30,002
Next